Ads
-
Related paper
- Bad Boy with a Twist: Targeting the 37 kDa/67 kDa Laminin Receptor for Treatment of Cancer and Neurodegenerative Diseases and for Changing Telomere Dynamics
- Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases
- GLOBAL ONGOING TRENDS IN DRUG DESIGNING FOR THE TREATMENT OF TYPE 2 DIABETES AND NEURODEGENERATIVE DISEASES
- CANCER DIAGNOSTICS, IMAGING AND TREATMENT BY NANOSCALE STRUCTURES TARGETING
- Identifying Gene Signatures Associated with Cancer Stem Cells and Drug Resistance from Triple Negative Breast Cancer Cells after Gene Targeting Treatment
- Telomere in Aging and Age-related Diseases
- Molecular targeting drugs for treatment of lung cancer patientsPrevention of adverse skin reactions and their care
- THERAPEUTIC TARGETING OF HYPOXIA-INDUCIBLE FACTOR SIGNALING PATHWAYS- A PROMISING APPROACH IN CANCER TREATMENT
- Correlation Of Oncotype DX Recurrence Score With The Expression Of Insulin Receptor Substrate Proteins In Estrogen Receptor + Breast Cancer
- Molecular Evaluation of Subtypes of Breast Cancer by Immunohistochemical expression of Estrogen Receptor(ER), Progesterone Receptor(PR), Her2neu,Cytokeratin 5/6 and Ki 67